IkappaBalpha is required for marginal zone B cell lineage development

Tools

Item Type:	Article
Title:	IkappaBalpha is required for marginal zone B cell lineage development
Creators Name:	Ellinghaus, U., Rupec, R.A., Pabst, O., Ignatius, R., Foerster, R., Doerken, B. and Jundt, F.
Abstract:	Inactivation of members of the nuclear factor-kappaB (NF-kappaB) family results in the decrease or defect of marginal zone B (MZB) cells. It is not known which inhibitors of the NF-kappaB family (IkappaB) are required for MZB cell development. Here, we show that mice with B cell-specific inactivation of the main NF-kappaB inhibitor IkappaBalpha have a marked decrease of MZB cells and their presumed precursors. They exhibited increased mortality rates after blood-borne bacterial infection, indicating the importance of MZB cells for bacterial clearance. In contrast, response to T cell-dependent and -independent antigens resulted only in minor changes in immunoglobulin production. Our data demonstrate the importance of the intact NF-kappaB/IkappaBalpha pathway for proper MZB cell development.
Keywords:	Conditional Knockout, Marginal Zone B Cells, NF-B Pathway, Animals, Mice
Source:	European Journal of Immunology
ISSN:	0014-2980
Publisher:	Wiley
Volume:	38
Number:	8
Page Range:	2096-2105
Date:	August 2008
Official Publication:	https://doi.org/10.1002/eji.200838254
PubMed:	View item in PubMed

Repository Staff Only: item control page